
    
      Primary objective To investigate treatment response to NEXIUM in patients with reflux
      esophagitis (RE).

      Secondary objectives

      To investigate following items in patients with RE:

        1. Patient satisfactory level of the treatment for RE

        2. Health-related quality of life (HRQOL)

        3. Severity and frequency of RE symptoms reported by physicians

        4. Endoscopic healing rate

        5. Development of ADRs
    
  